A case of cytokine release syndrome accompanied with COVID-19 infection during treatment with immune checkpoint inhibitors for non-small cell lung cancerArticle Published on 2022-10-012022-11-15 Journal: Thoracic cancer [Category] 진단, [키워드] accompanied adverse events Cancer Cancer immunotherapy Cancer patients Cardiopulmonary caused Cell Colitis COVID-19 infection CRS cytokine release Cytokine release syndrome develop diagnosed diagnosed with COVID-19 diarrhea disease dose drugs examination Factors Fever Immune checkpoint inhibitor immune-related adverse events. Infection intensive care interleukin-6 Ipilimumab lung adenocarcinoma lung cancer nivolumab Patient patients postoperative returned SARS-CoV-2 syndrome systemic inflammatory the patient Treatment variety was performed with COVID-19 [DOI] 10.1111/1759-7714.14632 PMC 바로가기
Individualized, heterologous chimpanzee adenovirus and self-amplifying mRNA neoantigen vaccine for advanced metastatic solid tumors: phase 1 trial interim results Research Published on 2022-08-152022-10-05 Journal: Nature Medicine [Category] 변종, 유전자 메커니즘, 임상, 치료법, [키워드] Adenovirus adverse event analyses Analysis benefit Biomarker CD8 T cell circulating Colorectal cancer Combination CPI diarrhea disease DNA dose Endpoint fatigue feasibility feasible Heterologous immune inhibitor injection site pain Ipilimumab limit long-lasting mRNA Musculoskeletal nivolumab Patient phase 1 trial primary endpoint Pyrexia randomized studies reactivity regimen responses Safe Safety secondary solid tumor statistical survival therapy Tolerability toxicities transaminase translational Tumor vaccination Vaccine viral particle were assessed [DOI] 10.1038/s41591-022-01937-6 [Article Type] Research
Severe necrotizing myopathy after COVID-19 vaccine with BNT162b2 and regimen with ipilimumab plus nivolumab in a patient with advanced melanoma진행성 흑색종 환자에서 BNT162b2를 사용한 COVID-19 백신 및 이필리무맙 + 니볼루맙 요법 후 중증 괴사성 근병증Article Published on 2022-02-012022-09-12 Journal: Journal of the European Academy of Dermatology and [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] BNT162b2 COVID-19 vaccine Ipilimumab Melanoma nivolumab Patient regimen [DOI] 10.1111/jdv.17760 PMC 바로가기 [Article Type] Article
Immune-related adverse events of COVID-19 vaccination in skin cancer patients receiving immune-checkpoint inhibitor treatmentResearch Report Published on 2021-12-232022-10-31 Journal: Cancer immunology, immunotherapy : CII [Category] COVID-19, [키워드] Adverse adverse event adverse events AEs antibody approved Cancer cancer patient Cancer patients clinical cohort study combination treatment coronavirus disease COVID-19 COVID-19 vaccination COVID-19 vaccine dose eight event fatigue first vaccination FIVE follow-up time Frequency Germany grade 3 Immune-checkpoint inhibitors Immunotherapy information inhibitor injection investigated Ipilimumab irAE median Melanoma men Mild moderate pain mRNA-based nivolumab Patient patients patients’ medical records Precaution receiving reported retrieved Safe Seven Side effect Side effects supplementary material the timing therapy treated Treatment vaccination Vaccine was used [DOI] 10.1007/s00262-021-03133-w PMC 바로가기 [Article Type] Research Report
Quantification of anti-SARS-CoV-2 antibodies in human serum with LC-QTOF-MSLC-QTOF-MS를 사용한 인간 혈청 내 항-SARS-CoV-2 항체 정량화Article Published on 2021-10-252022-09-11 Journal: Journal of pharmaceutical and biomedical analysis [Category] MERS, SARS, 진단, 치료기술, [키워드] Accuracy anti-SARS-CoV-2 anti-SARS-CoV-2 antibodies anti-SARS-CoV-2 antibody anti-SARS-CoV-2 IgG1 antibody concentration applicability assays Concentration COVID-19 demonstrated develop flight human serum IgG1 IgG1 antibodies IgG1 antibody IgM immunoassays Ipilimumab LC-QTOF-MS Liquid chromatography Magnetic beads mass mass spectrometry Mild Other Patient PCR-positive patient peptide Precision Protein quantification quantified Quantitative SARS-CoV-2 SARS-COV-2 infection semi-quantitative serological test serum severe symptoms spike Spike protein subunit unique was selected [DOI] 10.1016/j.jpba.2021.114319 PMC 바로가기 [Article Type] Article
Case Report: Dual Checkpoint Inhibition in Advanced Metastatic Osteosarcoma Results in Remission of All Tumor Manifestations—A Report of a Stunning Success in a 37-Year-Old Patientarticle Published on 2021-08-062024-09-02 Journal: Frontiers in Oncology [Category] 대상포진, [키워드] dual checkpoint inhibition Immunotherapy Ipilimumab nivolumab osteosarcoma [DOI] 10.3389/fonc.2021.684733 PMC 바로가기 [Article Type] article
Exploring antibody repurposing for COVID-19: beyond presumed roles of therapeutic antibodiesCOVID-19에 대한 항체 용도 변경 탐색: 추정되는 치료 항체의 역할을 넘어서Article Published on 2021-05-132022-08-31 Journal: Scientific Reports [Category] SARS, 신약개발, 임상, 진단, [키워드] activity antibodies antibody bypassing clinical trials Computational biology and bioinformatics COVID-19 CTLA4 diagnostic diagnostic test drug dual effective elevated epitope evaluated IL17A immunology Immunosuppression in silico Infection Interaction Ipilimumab medical condition monoclonal antibodies Neutralizing antibodies provide repurposing researcher SARS-COV-2 infection SARS-CoV-2 neutralizing antibodies SARS-CoV-2 neutralizing antibody sequence sequences severe SARS severe SARS-CoV-2 shown therapeutic Treatment treatment of COVID-19 Tremelimumab Vaccine Viral viral neutralization widespread [DOI] 10.1038/s41598-021-89621-6 PMC 바로가기 [Article Type] Article
Diffuse pneumonitis from coronavirus HKU1 on checkpoint inhibitor therapyCase Report Published on 2020-05-192022-10-30 Journal: Journal for immunotherapy of cancer [Category] COVID-19, MERS, [키워드] acute respiratory syndrome adverse event association Brain case reports coronavirus Coronavirus infection COVID-19 pandemic CT scan diagnosed diffuse Dyspnea early-onset evidenced exacerbated ground glass HKU1 Immune-mediated immunomodulation Immunotherapy Infection inhibitor Interaction Ipilimumab Melanoma nivolumab Non-COVID-19 Patient SARS-CoV-2 severity steroid therapy Toxicity treated [DOI] 10.1136/jitc-2020-000898 PMC 바로가기 [Article Type] Case Report
CTLA-4 antibody ipilimumab negatively affects CD4 + T-cell responses in vitroCTLA-4 항체 이필리무맙은 시험관 내에서 CD4 + T 세포 반응에 부정적인 영향을 미칩니다Original Article Published on 2019-07-222024-07-30 Journal: Cancer Immunology, Immunotherapy [Category] 파상풍, [키워드] Coinhibitory pathways CTLA-4 Immune checkpoints Ipilimumab tetanus toxoid [DOI] 10.1007/s00262-019-02369-x PMC 바로가기 [Article Type] Original Article
Immune checkpoint inhibitors in challenging populationsReview Published on 2017-06-012023-06-19 Journal: Cancer [Category] B형 간염, Fulltext, [키워드] Autoimmune elderly Ipilimumab nivolumab organ dysfunction pediatrics Pembrolizumab Pregnancy Transplant [DOI] 10.1002/cncr.30642 PMC 바로가기 [Article Type] Review